US BARDA (HHS)

Helps United States BARDA through advanced medical countermeasure programs for public health preparedness.

The Biomedical Advanced Research and Development Authority (BARDA) operates inside HHS’s Assistant Secretary for Preparedness and Response and focuses on advancing medical countermeasures for public-health emergencies and national preparedness. Its mandate is development-stage support for pandemic, chemical, and radiological risk domains, with emphasis on products that can move toward national readiness use.

This funder profile indicates a named grant track with a maximum award amount of $500,000,000, consistent with the scale expected for late-stage development and manufacturing-readiness work. BARDA is positioned as a mission-driven development authority rather than a broad open-discovery grant program.

For applicants, relevance is strongest when the work is at a stage where a near-to-market countermeasure pathway can be justified through preparedness need, milestone discipline, and government transition value.